Latest Advances in Lymphocytic Colitis

Latest Advances

Latest Advance
  • Condition: Refractory Microscopic Colitis (MC)
  • Journal: Journal of Crohn's & colitis
  • Treatment Used: Vedolizumab
  • Number of Patients: 11
  • Published —
This study evaluated clinical remission with vedolizumab in budesonide-refractory patients with microscopic colitis (inflammation of colon; MC).
Latest Advance
  • Condition: Induction Therapy For Lymphocytic Colitis
  • Journal: Gastroenterology
  • Treatment Used: budesonide versus mesalazine versus placebo
  • Number of Patients: 57
  • Published —
The purpose of the study was to evaluate budesonide and mesalazine as induction therapy for lymphocytic colitis.
Showing 1-2 of 2